Overall Score

Financial Health

Liquidity remains tight with a current ratio of 0.75 and negative working capital of -$957.4M.

Leverage is very high, with debt-to-equity at 35.6x and debt-to-capital at 97.3%.

Cash generation remains weak, as operating cash flow is negative and free cash flow yield is -30.8%.

Profitability

Margins are deeply negative, with net margin at -11.8% and EBITDA margin at -9.6%.

Returns remain poor, with ROE at -17.1% and ROIC at -6.9%.

Asset efficiency is weak, with asset turnover at 0.02 and operating ROA at -5.0%.

Valuation Risk

Valuation remains extremely rich, with EV/Sales at 65.0x and price/sales at 49.2x.

Price/book is also elevated at 54.1x despite weak profitability.

Negative earnings and cash flow make traditional valuation support limited.

Operational Execution

Gross margin is still healthy at 56.4%, but it is not translating into operating profit.

Capex intensity is very high, with capex/revenue at 13.5x and capex/operating cash flow at 8.0x.

Working-capital efficiency is distorted by very long payables days, suggesting strained operating dynamics.